March 27, 2026

Mental Health Content Accuracy Varies

Researchers found misinformation rates ranged from 0% to 57% across platforms and topics, with higher rates reported in several TikTok studies compared with YouTube.

Conexiant

March 27, 2026

ACSM Revises Resistance Training Guidance

Synthesized evidence clarifies which training variables enhance strength, hypertrophy, and performance.

Conexiant

March 26, 2026

GLP-1 Drugs Examined in Psychiatric Outcomes

Researchers evaluate mental health trajectories with antidiabetic therapies in patients with depression or anxiety.

Conexiant

March 26, 2026

The Hidden Differences Between Oral Contraceptives

National adverse-event and prescribing data suggest oral contraceptive formulations differ in reported acne, migraine, anxiety, and depression 

Conexiant

March 26, 2026

Trial Tests Single-Day TRD Treatment 

Randomized trial found more than half of treated patients achieved remission within 8 days.

Conexiant

March 24, 2026

Moral Distress Associated With Physician Burnout

Researchers link distress to burnout, professional fulfillment, and intent to leave or reduce clinical hours.

Conexiant

March 23, 2026

Physician Disability, Exit Risk Rise

Researchers examine disability, accommodations, and clinical practice patterns in a national physician survey.

Conexiant

March 23, 2026

Researchers Propose TMD Definition for GBD

Consensus description may support inclusion in Global Burden of Disease estimates.

Conexiant

March 23, 2026

Influencer Drug Promotion Raises Concerns

Study highlights regulatory gaps and persuasive risks in social media marketing

Conexiant

March 23, 2026

No Clear Benefit for Psychedelic Therapy

A review of 24 studies found similar depression outcomes, suggesting apparent psychedelic benefits may reflect expectancy effects and weaker placebo responses 

Conexiant